Skip to Content
MilliporeSigma
All Photos(1)

Documents

211265

Sigma-Aldrich

4-Phenoxybenzaldehyde

98%

Sign Into View Organizational & Contract Pricing


About This Item

Linear Formula:
C6H5OC6H4CHO
CAS Number:
Molecular Weight:
198.22
Beilstein/REAXYS Number:
1947841
EC Number:
MDL number:
UNSPSC Code:
12352100
PubChem Substance ID:
NACRES:
NA.22

assay

98%

refractive index

n20/D 1.611 (lit.)

bp

185 °C/14 mmHg (lit.)

mp

24-25 °C (lit.)

density

1.132 g/mL at 25 °C (lit.)

SMILES string

O=Cc1ccc(Oc2ccccc2)cc1

InChI

1S/C13H10O2/c14-10-11-6-8-13(9-7-11)15-12-4-2-1-3-5-12/h1-10H

InChI key

QWLHJVDRPZNVBS-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Application

4-Phenoxybenzaldehyde was used in the synthesis of:
  • spirodiketopiperazine derivatives
  • benzoxazoles

Storage Class

10 - Combustible liquids

wgk_germany

WGK 3

flash_point_f

230.0 °F - closed cup

flash_point_c

110 °C - closed cup

ppe

Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

Kelly J McClure et al.
Bioorganic & medicinal chemistry letters, 16(7), 1924-1928 (2006-01-31)
In a recent paper, [Arienti, K. L.; Brunmark, A.; Axe, F. U.; McClure, K. M.; Lee, A.; Blevitt, J.; Neff, D. K.; Huang, L.; Crawford, S.; Chennagiri, R. P.; Karlsson, L.; Brietenbucher, J. G. J. Med. Chem.2005, 48, 1873], we
Rena Nishizawa et al.
Bioorganic & medicinal chemistry letters, 17(3), 727-731 (2006-11-23)
Hydroxylated derivatives were designed and synthesized based on the information of oxidative metabolites. Compounds derived from beta-substituted (2R,3R)-2-amino-3-hydroxypropionic acid showed improved inhibitory activities against the binding of MIP-1alpha to human CCR5, compared with the non-hydroxylated derivatives and the other isomers.
Vikas N Telvekar et al.
Bioorganic & medicinal chemistry letters, 22(1), 649-652 (2011-11-15)
A series of structurally novel, substituted 2-(2-(4-aryloxybenzylidene) hydrazinyl)benzothiazole derivatives incorporating 2-hydrazinyl benzothiazole and 4-(aryloxy)benzaldehyde were designed and synthesized using molecular hybridization approach. All the synthesized compounds exhibited promising activity (MIC 1.5-29.00μg/ml) against Mycobacteriumtuberculosis H37Rv strains of using REMA. Five of

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service